posted on 2021-09-13, 15:08authored byDouglas Barthold, Elizabeth Brouwer, Lee J. Barton, David E. Arterburn, Anirban Basu, Anita Courcoulas, Cecelia L. Crawford, Peter N. Fedorka, Heidi Fischer, Benjamin B. Kim, Edward C. Mun, Sameer B. Murali, Kristi Reynolds, Tae K. Yoon, Robert E. Zane, Karen J. Coleman
<b>Objective:</b> There
are few studies testing the amount of weight loss necessary to achieve initial
remission of type 2 diabetes (T2DM) following bariatric surgery and no
published studies using weight loss to predict initial T2DM remission in sleeve
gastrectomy (SG) patients.
<p><b>Research
Design and Methods:</b> Cox
proportional hazards models examined the relationship between initial T2DM
remission and percent total weight loss (%TWL) after bariatric surgery. Categories
of %TWL were included in the model as time-varying covariates. </p>
<p><b>Results:</b> Patients (N=5,928) were 73% female,
49.8<u>+</u>10.3 years old, had BMI of 43.8<u>+</u>6.92 kg/m<sup>2</sup>, and 57%
had Roux-en-Y gastric bypass (RYGB). Over an average follow-up of 5.9 years,
71% of patients experienced initial remission of their T2DM (mean time to
remission 1.0 year). Using 0-5% TWL as the reference group in Cox proportional
hazards models, patients were more likely to remit with each 5% increase in TWL
until 20% TWL (range from HR=1.97 to 2.92). When categories above >25% TWL
were examined, all had a likelihood of initial remission similar to 20-25% TWL.
Patients who achieved >20% TWL were more likely to achieve initial T2DM
remission than patients with 0-5% TWL, even if they were using insulin at the
time of surgery.</p>
<p><b>Conclusions:
</b>Weight loss after
bariatric surgery is strongly associated with initial T2DM remission; however, above
a threshold of 20% TWL, rates of initial T2DM remission did not increase
substantially. Achieving this
threshold is also associated with initial remission even in patients who
traditionally experience lower rates of remission, such as patients taking
insulin.</p>
Funding
Support for this study was provided by the National Heart, Lung, and Blood Institute (5R01HL130462). The funding source had no role in study design, data collection, data analysis, data interpretation, or writing of the article.